Members Capital Advisors Inc Bristol Myers Squibb CO Transaction History

Members Capital Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 30, 2023	SELL	$57.89 - $64.73 $556,091 - $621,796	-9,606 Reduced 30.3%	22,102 $1.28 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $289,447 - $347,073	4,708 Added 17.44%	31,708 $2.32 Million
Q3 2020 Nov 04, 2020	BUY	$57.43 - $63.64 $1.55 Million - $1.72 Million	27,000 New	27,000 $1.63 Million

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Members Capital Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Members Capital Advisors Inc with notifications on news.